• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
2022 Nelson's Pediatric Antimicrobial Therapy

2022 Nelson's Pediatric Antimicrobial Therapy

9781610025645
283.50 zł
269.33 zł Save 14.17 zł Tax included
Lowest price within 30 days before promotion: 269.33 zł
Quantity
Product unavailable
Temporarily unavailable

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.
;
For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.
;
TOPICS INCLUDE
  • Antimicrobial Therapy by Clinical Syndromes
  • Antimicrobial Therapy for Neonates
  • Choosing Among
    • Antibiotics
    • Antifungal Agents
    • Antiviral Agents
    • Antiparasitic Agents
    • Oral Step-down Therapy for Serious Infections
    • Prevention of Symptomatic Infection
    • Approach to Antibiotic Allergies
    • Antibiotic Stewardship
    New in the 28th Edition
    • Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
    • Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
    • Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
    • Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
    • New dosing for posaconazole suspension formulation
    • New approaches to mucormycosis
    • Added baloxavir for children 12+ years old
Product Details
Eurospan
92926
9781610025645
9781610025645

Data sheet

Publication date
2022
Issue number
28
Cover
paperback
Pages count
370
Dimensions (mm)
121.00 x 171.00
Weight (g)
300
    • Introduction
    • Notable Changes to 2022 Nelson’s Pediatric Antimicrobial Therapy, 28th Edition
    • 1. Antimicrobial Therapy According to Clinical Syndromes
      A. Skin and Soft Tissue Infections
    • B. Skeletal Infections
    • C. Eye Infections
    • D. Ear and Sinus Infections
    • E. Oropharyngeal Infections
    • F. Lower Respiratory Tract Infections
    • G. Cardiovascular Infections
    • H. Gastrointestinal Infections
    • I. Genital and Sexually Transmitted Infections
    • J. Central Nervous System Infections
    • K. Urinary Tract Infections
    • L. Miscellaneous Systemic Infections
  • 2. Antimicrobial Therapy for Neonates
    A. Recommended Therapy for Selected Neonatal Conditions
  • B. Antimicrobial Dosages for Neonates
  • C. Aminoglycosides
  • D. Vancomycin
  • E. Use of Antimicrobials During Pregnancy or Breastfeeding
  • 3. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
    A. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
  • B. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
  • C. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
  • D. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
  • 4. Choosing Among Antibiotics Within a Class:: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
  • 5. Preferred Therapy for Specific Fungal Pathogens
    A. Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
    B. Systemic Infections
  • C. Localized Mucocutaneous Infections
  • 6. Choosing Among Antifungal Agents:: Polyenes, Azoles, and Echinocandins
  • 7. Preferred Therapy for Specific Viral Pathogens
    A. Overview of Non-HIV, Non-hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
  • B. Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
  • C. Preferred Therapy for Specific Viral Pathogens
  • 8. Choosing Among Antiviral Agents
  • 9. Preferred Therapy for Specific Parasitic Pathogens
    A. Selected Common Pathogenic Parasites and Suggested Agents for Treatment.
  • B. Preferred Therapy for Specific Parasitic Pathogens
  • 10. Choosing Among Antiparasitic Agents:: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and Neglected Tropical Diseases
  • 11. How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
  • 12. Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus
  • 13. Antibiotic Therapy for Children Who Are Obese
  • 14. Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
  • 15. Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
    A. Postexposure Antimicrobial Prophylaxis to Prevent Infection
  • B. Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
  • C. Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
  • D. Surgical/Procedure Prophylaxis
  • 16. Approach to Antibiotic Allergies
  • 17. Antibiotic Stewardship
  • 18. ;Systemic and Topical Antimicrobial Dosing and Dose Forms
    A. Systemic Antimicrobials With Dosage Forms and Usual Dosages
  • B. Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
  • Appendix:: Nomogram for Determining Body Surface Area
  • References
  • Index
  • Comments (0)